FibroBiologics, Inc. Common Stock
Symbol: FBLG (NASDAQ)
0.55
▲ (1.24%) 0.007
Company Description:
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Key Stats
- Today's Open: $0.5502
- Today's High: $0.622
- Today's Low: $0.535
- Today's Volume: 651.19K
- Yesterday Close: $0.5383
- Yesterday High: $0.5746
- Yesterday Low: $0.5315
- Yesterday Volume: 561.12K
- Last Min Volume: 360
- Last Min High: $0.545
- Last Min Low: $0.545
- Last Min VWAP: $0.545
Company Profile
- Name: FibroBiologics, Inc. Common Stock
- Website: https://www.fibrobiologics.com
- Listed Date: 2024-01-31
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001958777
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $23.85M
- Round Lot: 100
- Outstanding Shares: 41.89M
- Asset Type: CS
RECENT FILINGS FOR FBLG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-08 | 8-K | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-18 | 8-K/A | View |
| 2025-07-18 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-03 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 3 | View |
| 2025-06-09 | 8-K | View |
| 2025-06-06 | SCHEDULE 13G | View |
| 2025-05-27 | 4 | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-05 | 8-K | View |
Latest News on FBLG